We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
Public health authorities in France have reported a locally-acquired case of chikungunya in the Paris area. Based on current public information, the case was infected in Paris or neighbouring Gennevilliers.
Chikungunya is rare in European countries but is occasionally transmitted by Aedes mosquitoes. These are widespread in France and are now known to occur in the Paris area.
Chikungunya is a viral infection spread by mosquito bites and can cause acute fever and severe joint pain. There is no vaccine available against chikungunya.
Travellers to affected areas are potentially at risk of chikungunya and should be aware of this infection. Aedes mosquitoes are particularly persistent and aggressive. They bite between dawn and dusk.
Travellers developing a fever during or on return from travel are advised to seek medical attention as soon as possible.
For further information see TRAVAX chikungunya page.
